Qiagen, Agilent Post Strong Gains in BCW Index | GenomeWeb

Qiagen and Agilent both had strong stock gains during the past week, leading the BioCommerce Week Index of multi-platform molecular biology tool firms. Qiagen shares rose 10 percent, though the reason for the upward movement is not readily apparent. Agilent's shares climbed 9.78 percent, due largely to a report in the Wall Street Journal that the firm's semiconductor business could be sold as early as late this week for as much as $2.5 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.